A Qualitative Study on Gratitude and Recognition Toward Living Kidney Donors

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Kidney transplantation is widely recognized as the best treatment for patients with end-stage renal disease. However, its development is limited by the persistent shortage of available organs. Living donor kidney transplantation offers the best functional and survival outcomes, yet the number of procedures remains insufficient.

Living kidney donation relies on a voluntary and altruistic act by a healthy individual who accepts surgery without direct medical benefit. This act of generosity raises important questions regarding how society acknowledges and values such commitment. The lack of formal recognition may contribute to the psychological burden experienced by some donors and may not adequately reflect the gratitude of the medical community and society toward them.

This study aims to explore the perceptions of living kidney donors regarding the potential implementation of a symbolic form of recognition (for instance, a commemorative medal) offered after donation. The hypothesis is that such recognition could improve donors' post-donation experience and strengthen the societal value associated with living organ donation, while fully respecting ethical principles prohibiting any financial reward.

This is a qualitative, monocentric study based on semi-structured interviews with individuals who have donated a kidney. The interviews will focus on donors' motivations, their personal experience of donation, and their opinions about different possible forms of post-donation recognition. Interviews will be recorded, transcribed verbatim, and analyzed using inductive thematic analysis to identify recurring themes and perspectives.

The main endpoint is the identification of thematic categories related to donors' perception of post-donation recognition and its potential impact on their experience. Secondary objectives include exploring donors' expectations regarding societal gratitude, their views on the symbolic value of such recognition, and the potential influence on future donor engagement.

The findings of this study are expected to contribute to the ethical reflection surrounding the acknowledgment of living donors, support initiatives promoting non-financial recognition, and help develop respectful and meaningful ways of expressing societal gratitude toward those who make the gift of life possible.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Individuals who have donated a kidney at Hôpital Saint-Louis between January 1, 2020, and December 31, 2025, or are currently engaged in a living kidney donation process with nephrectomy scheduled before June 30, 2026.

Age ≥ 18 years.

Able to provide informed consent.

Disqualifiers

Refusal or opposition to participate in the study.

Individuals under legal protection (guardianship, curatorship, or legal safeguard).

Individuals deprived of liberty by judicial or administrative decision.

Individuals under 18 years of age.

Trial design

Design model

Single group

Treatments tested in this trial

  • Semi-structured qualitative interview

    Behavioral

    Participants will take part in a one-on-one semi-structured qualitative interview exploring their experiences and perceptions related to living kidney donation and potential forms of post-donation recognition. The interview guide includes open-ended questions addressing: * Personal motivations for donation; * Emotional and relational experiences throughout the donation process; * Ethical perceptions of living donation; * Views on symbolic recognition (e.g., commemorative medal, public acknowledgment, ceremony); * Perceptions of paired kidney donation (KPD); * Social representations of living donation in their personal environment and in society. Interviews will last approximately 45 to 60 minutes and will be conducted either in person at Hôpital Saint-Louis or via secure videoconference. All interviews will be recorded, transcribed verbatim, anonymized, and analyzed using inductive thematic analysis (NVivo or equivalent software).

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Living donors of KidneyOther 1 intervention

Trial outcomes

Primary outcomes

1

Themes related to donor perceptions of post-donation recognition

Inductive thematic analysis of semi-structured interviews with living kidney donors, identifying key themes and subthemes related to their perception of post-donation recognition or symbolic rewards (e.g., commemorative medal, public acknowledgment).

Time frame
At baseline

Secondary outcomes

1

Perceptions of Kidney Paired Donation (KPD)

Exploration of participants' views and emotional responses toward kidney paired donation programs, including ethical and logistical aspects. A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

Time frame
At baseline
2

Initial Motivations for Donation

Identification of personal, relational, or altruistic motivations that led participants to consider or complete living kidney donation. A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

Time frame
At baseline
3

Experience of the Donation Pathway

Evaluation of participants' experiences throughout the donation process, including emotional journey, perceived support, and acknowledgment by healthcare professionals. A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

Time frame
At baseline
4

Ethical Perceptions of Living Donation and Symbolic Recognition

Analysis of ethical reflections expressed by donors regarding the concept of recognition, symbolic rewards, or institutional gratitude (e.g., medals, diplomas, ceremonies). A semi-structured interview lasting 30-60 minutes, either in person during another scheduled treatment or via videoconference.

Time frame
At baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: